Social Determinants of Health: The Impact on Health Outcomes and Hospital Profitability by MCPHERSON, DANIELLE
Washington University in St. Louis 
Washington University Open Scholarship 
Doctor of Business Administration 
Dissertations Olin Business School 
Fall 12-19-2020 
Social Determinants of Health: The Impact on Health Outcomes 
and Hospital Profitability 
DANIELLE MCPHERSON 
Follow this and additional works at: https://openscholarship.wustl.edu/dba 
 Part of the Econometrics Commons, Economic Policy Commons, Finance Commons, Finance and 
Financial Management Commons, Health Economics Commons, Health Policy Commons, and the 
Regional Economics Commons 
Recommended Citation 
MCPHERSON, DANIELLE, "Social Determinants of Health: The Impact on Health Outcomes and Hospital 
Profitability" (2020). Doctor of Business Administration Dissertations. 10. 
https://openscholarship.wustl.edu/dba/10 
This Dissertation is brought to you for free and open access by the Olin Business School at Washington University 
Open Scholarship. It has been accepted for inclusion in Doctor of Business Administration Dissertations by an 





OF HEALTH:  








Hospitals are experiencing decreasing profitability due to 
increasing healthcare cost.  In this paper, I demonstrate that 
there is financial value to hospitals by addressing social 
determinants of health (SDOH) as this strategy improves 
health outcomes and yields cost savings. I estimate the impact 
of SDOH on the health outcomes using an IV probit regression 
analysis and estimated the impact of health outcomes on cost 
using a basic linear regression. I estimate that improving 
SDOH by one standard deviation will result in hospital cost 
savings as follows: addressing Violent Crime will decrease 
hospital cost between 0.16% and 0.21%, addressing 
Supplemental Nutrition Assistance program will decrease cost 
up to 0.5% and addressing Unemployment will decrease 
hospital cost between 1.2% and 1.7% resulting in a favorable 
impact on hospital profitability. I use the HCUP National 
Inpatient Sample 2014 dataset along with externally identified 
variables representing SDOH to estimate cost savings. 




 Healthcare costs have been consistently increasing every year since the 
1960s.   They account for nearly 17.5% of GDP as recent as 2018 and they are 
on a trajectory to top 20% of GDP by 2025 according to the Centers for Medicare 
and Medicaid Services (CMS)1. There are several factors that are attributing to 
the increases in healthcare costs and the erosion of hospital profitability 
including increases in general & administrative expenses, aging patient 
population, growing population,  and more incidents of disease (Dielman et.al., 
2017).  Profitability is also being affected from a revenue  perspective due to 
decreasing negotiated reimbursement rates  from Commercial (e.g., private, 
employer) Payers (i.e., United Healthcare, Humana, Aetna, etc.) as a result of a 
shift  from Fee-for-Service to  Value Based Care models and rate reductions for 
services from Government Payers (i.e., Medicare and Medicaid).   
Of the total population in the US, the individuals insured by the 
Government Payers accounts for the second largest portion of the patient mix for 
hospitals  behind those that are insured by their employer which are primarily 
covered by commercial Payers (see Figure 1).     
 
1 National Health Expenditure Projections 2015-2025: https://www.cms.gov/Research-Statistics-Data-and-
Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2015.pdf 





Employer insured health expenditures have continued to grow consistently since 
2013.  According to the 2017 Healthcare Cost and Utilization report (2019), 
spending per capita reached $5,641 per person and increased by 16.7 percent 
over a five-year period, which was an all-time high for individuals covered by 
their employers.  Fortunately, hospital reimbursement for services provided to 
individuals that are insured by their employers, is sufficient to cover the cost of 
care and therefore, does not have a negative impact on hospital profitability 
associated with Commercial Payers.   
Non-Group: Includes those covered by a policy purchased directly from an insurance company, etiher as policyholder or as dependent
Military: Includes those covered under the military or Veterans Administration
Uninsured: Includes those w ithout health insurance and those w ho have coverage under the Indian Health Service only
Employer: Includes those covered through a current or former employer or union, either as policyholder or as dependent
Government: Includes those covered by Medicare, Medicare Advantage, and those w ho have Medicare and another type of non-Medicaid 
coverage w here Medicare appears to be the primary payer. Excludes seniors w ho also report employer-sponsored coverage and full-time w ork, 
and those covered by Medicare and Medicaid (dual eligibles).  Also includes those covered by Medicaid, Medical Assistance, Children's Health 
Insurance Plan (CHIP) or any kind of government-assistance plan for those w ith low  incomes or a disability, as w ell as those w ho have both 
Medicaid and another type of coverage, such as dual eligibles w ho are also covered by Medicare.
Sources : KFF estimates based on the 2008-2019 American Community Survey, 1-Year Estimates.  https://w w w .kff.org/state-category/health-
coverage-uninsured/health-insurance-status/ 
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The number of uninsured people peaked right after the 2008 economic 
crisis and began to decrease in 2013 after the Affordable Care Act passed and 
was put into effect.  Most of the reduction of the uninsured moved to the 
Government insured bucket as Medicare and Medicaid saw increases shortly 
after the passing of the Affordable Care act as well.    These two groups include 
the oldest population (Medicare) and the poorest population (Medicaid) which 
accounts for higher costs per capita compared to individuals covered by their 
employers.  In 2017, Medicaid reported the median healthcare expenditures per 
capita for people covered by Medicaid was $7,171 and $16,544 for people that 
were over the age of 65 (Medicaid.gov, n.d.).  Unlike those that are insured by 
their employers, the hospital reimbursement for services provided to individuals 
insured by Government Payers are not enough to cover the cost of care.  
Additionally, people covered by Government Payers are primarily low-income and 
often do not have the funds to cover any additional out-of-pocket costs (i.e., 
deductibles, coinsurance, copays) which results in large increases in 
uncompensated care (i.e., write-offs) by hospitals.   
Currently, hospitals are not being reimbursed sufficiently to cover the cost 
of care provided to the patients that are insured by Government Payers and 
trends reflect plummeting reimbursement rates for hospital services which adds 
to profitability erosion.  The reduction in reimbursement rates for Government 
Payers are due to legislative restraints enacted as part of the Affordable Care Act 
(i.e., Value Based Care programs) and productivity adjustments (Department of 
Human Services, 2018).  Figure 2 shows how Medicare and Medicaid 
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reimbursement rates for services provided by hospitals are projected to decrease 
over the next several years as a percentage of private (Commercial) payers.  
Figure 2: 
 




As the population demographic changes and more and more people are insured 
by Government Payers, CMS projects that over 80 percent of hospitals will lose 
money by treating Medicare and Medicaid patients.  “By the end of the long-
range projection period, Medicare and Medicaid payment rates for inpatient 
hospital services would both represent roughly 37 percent of the average level 
for private health insurance”, (Department of Health and Human Services, 2018) 
On the revenue side, Commercial Payers are following the lead of 
Government Payers and are shifting from fee-for-service reimbursement models 
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to a Value Based Care models.   The fee-for-service model reimburses hospitals 
based on the quantity of services they provide and individual patient utilization 
and cost, independent of health outcomes. Value Based Care put emphasis on 
health outcomes, and focuses on quality of services, population utilization and 
costs and incentivizes the hospitals by paying them bonuses for achieving the 
agreed upon quality measures through Pay-For-Performance, at-risk and shared 
savings arrangements, and penalties (Baker Tilly, 2016).   This shift is prompting 
the Payers to decrease negotiated reimbursements rates on the front-end and 
instead expect hospitals to appropriately manage the care of the patient by 
providing high quality service and keeping cost low and being compensated with 
bonuses on the backend.  However, all hospitals and providers have not fully 
adopted the new Value Based model and are still administering care more in line 
with fee-for service (Sokol, 2020).  Hospitals are billing procedures (i.e., 
surgeries) based on per units of service or item required for overall procedure 
versus pricing more services in bundled payments2 where all procedures are 
included in one rate which forces the hospitals to assume more risks.   
Additionally, approximately 52.5 percent of hospitals are paying doctors straight 
salary and 31.8 percent of hospitals are paying doctors based on their personal 
productivity which is consistent with fee-for-service payment models and only 
13.1 percent are paid based on the hospital’s financial performance  and bonuses 
which is consistent with Value Base Care model (Rama, 2018).  This is resulting 
 
2 According to the American Hospital Association, “bundled payment programs generally provide a single, 
comprehensive payment that covers all of the services involved in a patient's episode of care” 
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in lower upfront revenue and increased cost because hospitals have not 
strategically kept pace with the direction Payer reimbursement models are going, 
and it is creating a large gap between the cost of care and the reimbursement for 
care of patients.   Figure 3 highlights our current healthcare environment, where 
we see healthcare revenue increasing, but at a decreasing rate compared to prior 
years.  Also, healthcare cost is increasing at a faster rate than healthcare 




Source: Modern Healthcare: https://www.modernhealthcare.com/finance/3-hallmarks-cost-disciplined-health-system-
and-profiles-success  
 
Hospitals are running out of ways to increase revenue in their quest to 
combat decreased profitability.  Simply attempting to negotiate higher rates with 
Payers is no longer sufficient.  The profitability erosion problem needs to be 
addressed through direct medical cost starting with the hospitals.  There are 
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other areas of a health system3 that attributes to increasing healthcare costs, 
but the focus in this paper is hospital care as it accounts for approximately 
32.7% of healthcare spending, compared to 15.5% for physician services, 9.2% 
for prescription drugs, 4.4% for clinical services, 4.6% for skilled Nursing, 2.8% 
for home health care and 15.1% for other personal health care (Rama, 2020).   
There appears to be opportunity to decrease hospital cost by focusing on 
high-risk chronic patients that are covered by Government Payers because their 
reimbursement rates are low and often do not cover the cost of providing the 
services.  There are many patients that are on Medicaid or Medicare that have 
multiple chronic conditions.  “While just seventeen percent of Medicare patients 
live with more than six chronic conditions, they account for half of all spending 
on beneficiaries with chronic disease” (Bresnik, 2016).  Figure 4 shows the 










3 Hospitals within the Health System is the focus of this paper.  The Agency for Healthcare Research and Quality 
(AHRQ) defines Health Systems as, “an organization that includes at least one hospital and at least one group of 
physicians that provides comprehensive care (including primary and specialty care) who are connected with each other 
and with the hospital through common ownership or joint management 





Source: Health IT Analytics: https://healthitanalytics.com/news/analyzing-medicare-chronic-disease-prevalence-
spending-rates  
 
Over the years, hospitals have seen costs increase due to patients getting 
sicker and older and requiring more emergency room or inpatient hospital stays.  
Hospitals could reduce some of the cost by addressing the social determinants 
that are causing these high-risk chronic patients to be admitted to the hospital 
in the first place.   
 Per the Centers of Disease Control, conditions in places where people live, 
learn, work and play affect a wide range of health risks and outcomes.  These 
conditions are known as social determinants of health (SDOH).  SDOH has 
 been associated with various causes of health issues over the years.  The 
concept of SDOH was first introduced in the 1960’s under President Lyndon B. 
Johnson through US Policies designed to declare war on poverty which 
introduced Medicaid, Medicare, Welfare (i.e., food stamps), Job Corps and Head 
Start Programs (Johnson, 2018 p.5).  The creation of these programs was 
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indicative of a correlation between a person’s living environment and their ability 
to maintain good health.   
 This paper aims to test the extent to which SDOH causes unfavorable 
health outcomes (evidenced by comorbidities) resulting in higher hospital cost.  
Additionally, I show that improving SDOH by one standard deviation will result 
in hospital cost savings, thereby, improving profitability.  To do this, I regress 
hospital cost against comorbidities and specific key control variables (length of 
stay, Payer, Hospital Control, Hospital Bed Size and Service Lines) to determine 
the incremental cost associated with a patient with comorbidities.  I also perform 
an instrumental variable probit regression  where each comorbidity is regressed 
against the three SDOH endogenous variables, Violent Crime, Supplemental 
Nutrition Program distribution, and Unemployment while controlling for other 
comorbidities, race, gender, household income, and hospital location. Political 
Affiliation is used as an instrument in the IV regression since it is correlated with 
the SDOH, but uncorrelated with the comorbidities.  That incremental cost of 
the comorbidity from the linear regression and the causal impact of the SDOH 
on the comorbidity from the IV regression is used to calculate the cost savings 
generated from improving each SDOH by one standard deviation.  I estimate total 
hospital cost will decrease between 0.16% and 0.21% for Violent Crime 
improvements, up to 0.5% for Supplemental Nutrition Assistance Program 
improvements and between 1.2% and 1.7% for unemployment improvements 
resulting in a favorable impact on hospital profitability.  I also repeat the basic 
linear regression on hospital cost and the IV regression on the comorbidities on 
P a g e  | 10 
 
 
a subset of the dataset that consists of all observations containing DRG 470 – 
Major Joint Replacement without Major Complications.  This micro analysis is 
done to determine if the correlation and causation of SDOH to hospital cost is 
still present. 
 This paper is organized as follows:  The second section summarizes 
previous empirical and theoretical research related to eroding hospital 
profitability and the impact on SDOH on health outcomes.  The third section 
presents detail on the primary source data used to analyze the relationships of 
health outcomes and SDOH.  The fourth section presents the data methods used 
including the econometric models and the cost savings calculations.  The fifth 
section describes the empirical results.  Section six suggests future research 
possibilities because of some of the constraints of the dataset.  The seventh 
section discusses how health systems can change processes and influence 
policies to implement initiatives to improve SDOH resulting in improved 
profitability. Section 8 is the conclusion. 
II. Literature Review 
 In this section, I review some literature related to hospital profitability and 
its erosion over time.  Additionally, I review previous research that focuses on 
Medicaid patients or low-income patients and how treatment of those patients 
correlates to decreasing profitability 
Hospital Profitability  
Hospitals have been faced with finding ways to stay profitable for all lines 
of business.  Bai and Anderson (2016) measure profitability as the net income 
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from patient care services per adjusted discharge based on fiscal year 2013.  
Their study shows that 46% of hospitals are not profitable, and unprofitability 
of hospitals are more sensitive to not-for-profit hospitals and hospitals that treat 
a larger percentage of Medicare, Medicaid, and uninsured patients.  Freidman, 
Sood, Engstrom and McKenzie (2004) also studied hospital profitability for 
inpatient care by payer and noted that Medicaid was the least profitable 
compared to Medicare, Private Insurance, and self-pay.     
 Additionally, since over half the states participated in the Medicaid 
expansion, the total number of Medicaid members grew, but the reimbursement 
to hospitals for patient care did not.  “The largest public payers continue to 
underpay hospitals, data from the most recent American Hospital Association 
(AHA) Annual Survey of Hospitals revealed. Medicare and Medicaid 
reimbursement fell $76.8 billion short of the actual costs of treating beneficiaries 
in 2017.  Medicare reimbursement was $53.9 billion short of actual hospital 
costs, while Medicaid underpaid hospitals by about $22.9 billion” (Lapoint, 
2019).  Medicaid pays between $0.85 to $0.87 on the dollar from 2010-2018 for 
all charges incurred at the hospital.  With the growing number of Medicare 
patients (approximately 10,000 newly eligible people aging in per day) and the 
increased number of Medicaid patients and newly insured, low income, and 
exchange patients, hospitals are not seeing as many commercial patients in the 
ER or as inpatient admits (Deloitte Insights, 2018).     
Many of the high cost charges were being generated by the lowest 
reimbursed part of the business (Medicaid).  Therefore, some hospitals negotiate 
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higher rates on commercial business, expecting the excess amounts to 
compensate for the low reimbursement for Medicaid Patients (Barkholz, 2016).  
Wagner (2015) research highlights how the Medicaid expansion led to higher 
prices and how hospital administrators thought they would have to charge 
patients with private/commercial insurance enough to cover their services and 
the deficit generated by Medicaid or Medicare reimbursement.  There was a 
shifting from private insurance to Medicaid resulting in revenue losses holding 
patient mix constant. However, that shift does not support an increase in 
privately covered patients, noting cost shifting is not occurring in response to 
Medicaid Expansions.  Instead, they reduce charges for privately insured 
patients, causing privately insured to benefit from the Medicaid expansions in 
terms of hospital charges.  This is evidence that there must be other ways 
hospitals are addressing revenue losses caused by Medicaid Expansions.   
Social Determinants of Health 
 There is a significant amount of prior research that shows a connection 
between an individual’s socioeconomic status or certain social determinants of 
health and their health outcomes.  As it relates to a person’s income status, 
Lenhart (2017) research finds that higher wages result in lower overall mortality 
and lower income individuals have been more prone to death from their health 
issues.  When care is free of charge or there is no out-of-pocket cost to the 
patient, individuals increase their number of doctor visits by 5-10% (Nilsson and 
Paul, 2018), thereby increasing their chances of mitigating potentially 
devastating health issues.  There has been some difficulties in determining 
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causation between socioeconomic status and health outcomes which resulted in 
some literature taking some different approaches to find causation.  Allin and 
Stable (2012) research finds that effects of the socioeconomic status also could 
pass down to the children of the parents, causing them to suffer the same 
adverse health outcomes as their parents.  Additionally, the upward mobility of 
the child can be beneficial to the parent, and that parents, with both high and 
low socioeconomic status, can benefit from having a child with a high 
socioeconomic status (Zimmer, Hanson, Smith, 2016). 
 Another SDOH is residential segregation which focuses on the geographic 
location of the person.  People in poorer neighborhoods are documented to have 
significantly more ambulatory visits for ambulatory care sensitive conditions 
than people that live in more affluent neighborhoods (Roos, et al, 2005).   Other 
studies have looked at the variation of health gaps that exist across more 
developed and richer countries and have shown that low socioeconomic statuses 
lead to poorer health versus poor health leading to low socioeconomic status in 
richer more developed countries (Lleras-Muney, 2018).  This further supports 
the idea that where a person lives can have a negative effect on their health 
outcomes.   
There are also studies that link a person’s race/ethnicity and 
socioeconomic status to their health outcomes.  There are studies that correlate 
“white privilege” to better health outcomes by looking at body mass index (BMI) 
and associating the greater BMI of people with darker complexions to lower 
socioeconomic statuses and poorer health (Carson, 2015).  In some cases, a 
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hospital’s profitability would be affected if they took into consideration the 
sensitivities of racially and ethnically diverse individuals.  For example, the 
Hospital Readmission Reduction program of the Centers of Medicare and 
Medicaid Services assess penalties for hospital readmissions and studies found 
that after adding race/ethnicity along with low socioeconomic status of 
individuals into the readmissions penalty calculation, most hospital would see 
significant decreases to their penalty payments (Martsolf, et al, 2016).  This study 
opens the opportunity for other studies to look at sensitivities of race/ethnicity 
as it relates to risk adjustment for other areas.   
There has been some progress with hospitals investing in social 
determinants of health, however it is not clear that there was a clear connection 
between that investment and their profitability.  Horwitz et.al. (2020) discusses 
the “sizable” investments in social determinants of health by health systems, but 
also recognizes that those investments are not specific to community-based 
activities.  Many of those investments are health related and does not go too far 
beyond that, despite the ACA regulations that required tax exempt hospitals to 
do community needs assessments. 
My research will build on these findings and discuss how improving social 
determinants of health of individuals and can result in both better health 
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III. Data Sources 
Primary Data Source  
I use the 2014 Healthcare Cost and Utilization Project (HCUP) 4 National 
Inpatient Sample (NIS) which is sampled from the State Inpatient Database (SID) 
and accounts for all inpatient data submitted to and reported by HCUP as the 
primary source for the population I analyze.  “The NIS is a database of hospital 
inpatient stays derived from billing data submitted by hospitals to statewide data 
organizations across the U.S. These inpatient data include clinical and resource 
use information typically available from discharge abstracts. Researchers and 
policy makers use the NIS to make national estimates of health care utilization, 
access, charges, quality, and outcomes. The NIS covers all patients, including 
individuals covered by Medicare, Medicaid, or private insurance, and the 
uninsured. For Medicare, the NIS includes Medicare Advantage patients, a 
population that is missing from Medicare claims data but that comprises as 
much as 20 percent of Medicare beneficiaries. The NIS' large sample size enables 
analyses of rare conditions, uncommon treatments, and special patient 
populations” (Introduction to The HCUP National Inpatient Sample, 2014, p. 4). 
The details of the NIS are normally available to the public through HCUP 
approximately 3 years in arrears.  For example, the 2017 NIS Sample was just 
made available on September 1, 2020.  Therefore, at the time I began this 
research, the 2014 NIS Dataset was the most complete version of data to use at 
 
4 Detailed information on The HCUP National Inpatient Sample (NIS) 2014 can be found at http://www.hcup-
us.ahrq.gov 
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that time.  The NIS was redesigned in 2012 to improve the national estimates.  
This dataset was the last version of the NIS that only included the ICD-9-CM 
diagnosis and procedure codes (in 2015 the ICD-10 CM diagnosis and procedure 
codes were introduced).   Additionally, it included inpatient discharge data for 
the state of Maine, after not being included for the prior two years.  The hospital 
service line (discussed later) was also added as a new data element in 2014. 
 This dataset includes 7,071,062 total observations of inpatient discharge 
data. My analysis looks at all observations but focus on select data elements as 
the base of my research.  Unfortunately, all data elements were not provided for 
every observation, which resulted in some missing data and omitted data during 
the regression because of collinearity.  However, the amount of missing or 
omitted data was not significant enough to materially impact my results (which 
will be discussed later).    
The independent variables are the 29 comorbidities identified in the 
dataset.  Comorbidities, as defined by Valderas, et.al (2009), “the presence of 
more than 1 distinct condition in an individual”.  All the comorbidities are 
presented in the dataset as binary where 1 indicates that the comorbidity is 
present and 0 indicates the comorbidity is not present.  These comorbidities 












The control variables originally presented in the dataset were a mixture of 
continuous and categorical variables (except for the comorbidities).  Length of 
Stay (LOS) represents the amount of days a patient stays in the hospital after 
being admitted.  The LOS was added as a control variable because of its direct 
impact to hospital COST.  According to the Organization of Economic Co-






CHRONIC BLOOD LOSS ANEMICA CM_BLDLOSS
CONGRESTIVE HEART FAILURE CM_CHF










FLUID & ELECTROLYTE DISORDERS CM_LYTES 
METASTATIC CANCER CM_METS 
OTHER NEUROLOGICAL DISORDERS CM_NEURO 
OBESITY CM_OBESE
PARALYSIS CM_PARA
PERIPHERAL VASCULAR DISDORDERS CM_PERIVASC
PSYCHOSES CM_PSYCH 
PULMONARY CIRUCLATION DISORDERS CM_PULMCIRC 
RENAL FAILURE CM_RENLFAIL 
SOLID TUMOR WITHOUT METASTASIS CM_TUMOR 
PEPTIC ULCER DISEASE CM_ULCER 
VALVULAR DISEASE CM_VALVE
WEIGHT LOSS CM_WGHTLOSS
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(ALOS) is often used as an indicator of efficiency. All other things being equal, a 
shorter stay will reduce the cost per discharge and shift care from inpatient to 
less expensive post-acute settings” (OCED, 2020).  The LOS was originally a 
continuous variable that ranges from 1 to 365 days.  I reclassified the LOS to 7 
binary variables (0-4 days, 5-9 days, 10-14 days, 15-19 days, 20-24 days, 25-29 
days and 30 plus days) where 1 indicates the hospital stay falls within the 
variable’s specified days and  0 indicates it does not fall within those days. I 
group the LOS into those specific categories since 99.1% of all inpatient stays 
happen in the first 30 days.   
Hospital Control is another data element used as a control variable in the 
first regression.  Hospital Control is defined as the type of entity that has 
ownership of the hospital.  This data element was added as a control variable 
because research has shown that hospital ownership has a significant impact 
on hospital profitability.  Based on prior empirical research, there appears to be 
significant differences in financial performance of for-profit (private) hospitals 
and not-for profit hospitals (Shen, et.al., 2007).  In the data set, Hospital Control 
was originally presented as a categorical element where 1 indicated the hospital 
was owned by government or non-federal, 2 indicates private, non-profit 
ownership and 3 indicates private, investor-owned ownership.  These 3 
categories were reclassified to 3 separate binary variables for each Hospital 
Control type where 1 indicates ownership/control for the respective Hospital 
Control type and 0 represents no ownership/control.   
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Hospital Bed Size is also a data element used as a control variable in the 
first regression.  I view the bed size of the hospital as its capacity to take on 
patients which could be revenue generating. However, smaller hospitals may not 
have the same opportunity as larger hospitals to reap benefits of profitable lines 
of business and are not able to spread inpatient cost over a large amount of 
hospital beds.  Therefore, it is important to see the variation between the bed 
size of the hospital.  In the data set, the hospital bed sizes varied across 4 regions 
(Northeast, Midwest, Southern and Western) and was further measured by 
Hospital Location (described later).5 Therefore, what is considered small, medium 
and large in the Northeast Region may not be measured the same as it is in the 
Midwest region.  Hospital Bed Size was originally presented as a categorical 
element where 1 indicated a small number of hospital beds, 2 indicated a 
medium number of hospital beds and 3 indicated a large amount of hospital bed.  
I reclassified these 3 categories of bed size into 3 different binary variables where 
1 indicate the observation is that bed size (small, medium, or large) and 0 
indicates it is not. 
Payer is a data element used as a control variable in the first regression.  
Payer represents the primary expected payer of the patient’s hospital bills.  This 
can include a private insurance company, government insurance or the actual 
patient which may be responsible for the hospital bill if they do not have health 
insurance.  The specific payer type can tell you a lot about the patient including 
 
5 Detailed breakdown of Small, Medium, Large bed sizes are available at  https://www.hcup-
us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp 
P a g e  | 20 
 
 
their socio-economic status, which is critical in analyzing how that affects 
hospital cost and health outcomes. In the data set, Payer was originally 
presented as a categorical element where 1 indicated the patient was covered by 
Medicare, 2 indicated the patient was covered by Medicaid, 3 indicated the 
patient was covered by a private insurance including HMO (normally coverage 
offered by an employer), 4 indicated the self-pay and the patient is responsible, 
5 indicated no charge (unreimbursed Native Health), and 6 indicated the patient 
was covered by other types of insurances (i.e., Workers Compensation, 
CHAMPUS/VA, Indian Health Service, other government insurance).  I 
reclassified these 6 categories of Payers into 6 different binary variables where 1 
indicates the responsible party for the patient’s hospital bill is that of the variable 
(i.e., Medicare, Medicaid, etc.) and 0 indicates it is not.  
Lastly, I used the data element Service Line as a control variable for the 
first regression.  I added Service Line because all reasons for hospitalizations are 
not monolithic and each reason has its own unique impact to overall hospital 
profitability.  Service Line represents all discharges from the hospital and was 
originally presented in the dataset as a categorical element of hospitalization 
types where 1 indicated maternal/neonatal, 2 indicated mental 
health/substance abuse, 3 indicated injury, 4 indicated surgical and 5 indicated 
medical.  I reclassified each category into its own binary variable where 1 
indicated that the observation’s service line was the specific type specified (i.e., 
maternal/neonatal, injury, surgical, etc.) and 0 indicated that it was not. 
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The second regression went further to explain whether there is any type of 
impact to hospital COST because of a patient’s SDOH.  There have been several 
studies as noted in the Literature Review section, that discussed the correlation 
between an individual’s health outcomes and their socioeconomic 
circumstances.  The impact of an individual’s socioeconomic status on their 
health outcomes can be directly driven by an individual’s personal decisions 
such as choosing to forgo medications or follow-up doctor appointments due to 
their low-income status and not having the available funds to cover out-of-pocket 
costs (i.e., copays, deductibles, etc.) (Nilsson and Paul, 2018).  The impact on 
health outcomes can also be indirectly driven by circumstances outside of an 
individual’s control such as the lack of access to grocery stores  to obtain fresh 
nutritious food or living in a neighborhood with little to no access to healthcare 
providers (Lleras-Muney, 2018).   I selected comorbidities to represent an 
individual’s health outcome because comorbidities are a combination of multiple 
related diseases and diagnoses of an individual.  SDOH are combination of 
several socioeconomic factors that could also be related to a person’s health 
outcome based on prior research. 
This regression was more complex as I needed to look at the impact of the 
social determinants on all 29 comorbidities separately as dependent variables 
and with each social determinant as independent variables separately as well, 
while controlling for Race, Household Income, Hospital Location and other 
comorbidities that were not being analyzed as the dependent variable.   
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I had to look beyond the dataset elements to explore this assumption 
because SDOH were not captured at the point of admission for an inpatient 
hospital stay and therefore, the information is not reported in the NIS as of 2014.  
In 2019, CMS introduced some ICD-10-CM diagnosis codes that could be used 
to identify certain types of SDOH such as problems related to education, 
problems related to employment and unemployment, occupational exposure to 
risk factors, problems relates to physical environment, problems related to 
housing and economic circumstances, problems related to social environment 
and problems related to psychosocial circumstances (James, 2019).  
Unfortunately, this information was not collected in 2014 and is not consistently 
captured now.  Therefore, I had to create the variables using external information 
obtained from various sources.  My focus is on a patient’s living environment, 
food insecurities, and issues surrounding employment.  I obtained information 
on Violent Crime to analyze the living environment, gathered information on 
distribution of Supplemental Nutrition Assistance (SNAP) to analyze food 
insecurities and the unemployment rates to analyze issues around employment.  
All the amounts used to analyze the effects of the SDOH are grouped into the 
nine US Census divisions of the hospital as referenced in the HCUP 2014 NIS 
dataset.  Each division includes the specific states the US Census assigned based 
on geographical area. I group the SDOH by hospital division because trends and 
practice patterns vary across the United States and the division is the most 
detailed level to stratify the inpatient data I use for this research.  Therefore, the 
SDOH amounts could only be 1 of 9 values as shown in Appendix 1. 
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Violent Crime Rate was obtained from the FBI Crime in the United States 
by Region, Geographic Division, and State 2013-2014 Table 4.  Per this source 
data, violent crime is defined as murder and nonnegligent manslaughter, rape, 
robbery, and aggravated assault.  I present the value of violent crime as the 
average number of incidents per 100,000 people at the Hospital Division level 
(as defined by the NIS dataset) as a categorical variable.  I use an average number 
of incidents because the information included on the FBI report was for the time 
from July 2013 through June 2014.   
SNAP values were obtained from the USDA Food and Nutrition Services 
Supplemental Nutrition Assistance Program State Activity Report Fiscal Year 
2014.  I use the average monthly benefit per household from Table 2 of the report.  
The average amounts were presented in the report at the state level and I 
reclassify each state into the average monthly benefit per household at the 
Hospital Division level (as defined by the NIS dataset) and present as a 
categorical variable.   
Unemployment rates were obtained from the Kaiser Family Foundation 
State Health Facts as of September 2014.   The unemployment rates are based 
on the overall population of individuals that are 16 years or older and are 
considered employable and actively looking for work.  The unemployment rates 
are presented in the report at the state level and I reclassify each state into the 
Hospital Division level (as defined by the NIS dataset) and presented it as a 
categorical variable.   
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Race, Gender, Household Income and Hospital Location were all data 
elements available in the NIS dataset.   I selected these data elements to be 
control variables because they help identify the patient’s socioeconomic status 
and environment.    
Race represents the race of the patient at the time of hospitalization.  Race 
was originally presented as a categorical variable in the NIS dataset, but was 
only available for about 94% of the observations (approximately 6% of the Race 
data was missing).  The race categories were classified as 1 for white, 2 for black, 
3 for Hispanic, 4 for Asian or Pacific Islander, 5 for Native American and 6 for 
other.  I reclassify these categories into separate binary variables where 1 
indicated the patient was of that race identified by the variable (i.e., black, white, 
etc.) and 0 indicated that they were not.  All the missing variables defaulted to 
the Other race data element. 
Gender represents whether the patient is a male or a female.  Gender was 
already presented as a binary variable where 1 indicates female and 0 indicates 
male. 
Household Income represents the median household income quartiles 
based on the patients’ zip code. Household income was originally presented as a 
categorical data elements where 1 indicated households with incomes of $1 to 
$38,999, 2 indicated households with incomes of $39,000 to $47,999, 3 
indicated households with incomes of $48,000 to $62,999 and 4 indicated 
households with incomes of $63,000 or more.  I reclassify each household 
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income category into separate binary variables where 1 indicated the patient’s 
household income identified by the variable (i.e., $1 to $38,999, $63,000, etc.) 
and 0 indicates that the patient’s household income was not that specific 
category. 
Hospital Location represents the type of location (urban or rural) and the 
teaching status of the hospital that the patient was admitted to. I chose hospital 
location versus the location of the patient’s residence because I believe it better 
represents how the hospital is impacted by treating patients affected by the 
SDOH.  The Hospital Location was originally presented as a categorical data 
element where 1 indicated rural, 2 indicated urban/non-teaching and 3 
indicated urban/teaching.  As with the other control variables, I reclassify each 
hospital location category into its own separate binary variable where 1 indicate 
the patient’s hospital is in that specific location identified by the variable (i.e., 
rural, urban/teaching, etc.) and 0 indicates that the hospital is not in that 
specified location. 
IV. Data Method 
Econometric Model 
My analysis has two parts, the first part looks at the influence of 
comorbidities on hospital cost while controlling for length of stay, hospital 
control, hospital bed-size, payer (insurance) type, and service line.  The second 
part of the analysis explores if and to what extent SDOH cause those 
comorbidities and as a result, attributed to increases in hospital costs.  The first 
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part analysis consists of one dependent variable (COST).  The calculate variable 
COST is a formula based on total billed charges included in data set deflated by 
average cost to charge ratio6.    My primary assumption is that SDOH (SDOH) 
contributes to comorbidities (CM) which causes hospital inpatient cost (COST) 
to increase and profitability to erode.  So, my goal is to determine if there are 
cost savings to the hospital if the SDOH improved by one standard deviation.  To 
further explore this assumption, I perform two regression analyses, one linear 
regression and one instrumental variable regression and calculate potential 
savings based on improving the SDOH by one standard deviation. The first 
regression determines to what extent CMs affect COST while controlling for 
Length of Stay (LOSDAYS_*), Hospital Control (H_CONTRL_*), Hospital Bed Size 
(HOSP_BEDSIZE_*), Payer (PAY1_*), Services Line (SERVICELINE_*) and all 
comorbidities (CM_*).  The linear regression’s construction is as follows: 
Y= β0 + β1X1i + β2X2i + β3X3i + ……. βnXni + u 
Where: 
Y = COST 
X1 – X7 = Length of Stay variables  
X8 - X13= Payer variables 
X14 - X16= Hospital Control variables 
X17 - X19= Hospital Bed Size variables 
 
6  Cost to Charge Ratio = total Billed charges/total allowable cost 
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X20 - X24= Service Line variables 
X20 - X48= All the comorbidities variables 
u = error term 
In the second regression, I explore the factors behind the comorbidities 
because per the assumption above, I believe at some level, SDOH causes an 
individual’s comorbidities along with other control variables.  I regress the three 
SDOH variables (i.e., Violent Crime, SNAP, and Unemployment) and all 29 
comorbidities and controlled for Race, Gender, Income Level, and Hospital 
Location.   Since the comorbidities are binary and are also the dependent 
variables, the regression would be a probit regression.  
To account for the potential endogeneity problem, I use an Instrumental 
Variable (IV) approach.  To further exploit the SDOH, I needed to identify a 
unique variable that would help me isolate the piece of the SDOH that is 
uncorrelated with the error term but is correlated with SDOH.  To do this, I would 
need to do an instrumental variables regression (IV).  I selected Political 
Affiliation of the region of all patients in the data set as the IV instrument 
because it is correlated with the SDOH directly through legislation that 
determines socioeconomic outcomes as a result of laws passed or indirectly 
through legislation or policy that are heavily influenced by the dominant Political 
Affiliation of the patient’s region.  Political Affiliation fulfills all OLS assumptions 
including the instrumental variable (IV) assumption of instrument relevance and 
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instrument exogeneity because it correlates to SDOH, but it is not driven by the 
individual’s comorbidity. 
Political Affiliation (i.e., Democrat, Republican) serves as a proxy for 
governmental policies reflected in the geographic division of which the SDOH are 
identified.  Often the policies that are in place are swayed by the position of the 
political affiliation that is dominant in that area.  For example, Democrat leaning 
areas may favor more government funding which would result in having a larger 
amount of average SNAP distributions per household.  Also, Republican leaning 
areas may favor policies that discourage government spending and executive 
overreach which a lot of times includes financial assistance that may help 
disenfranchised communities at large and could result in higher levels of 
unemployment.  Democrats and Republicans have varying views on crime as 
well, ranging from demanding harsher penalties for offenders (Republicans) to 
being in favor of police reform because of over-policing (Democrats).  SNAP’s 
distribution amounts are directly determined by governmental policies since the 
household allocation amounts and requirements around how those amounts are 
distributed, are voted on and decided by a specific state’s elected officials. 
Unemployment is indirectly caused by government policies but are heavily 
impacted by government policies such as monetary policy, fiscal policy, 
outsourcing, etc.  Violent Crime is partially driven by government policy and 
partially by sociological circumstances.  
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Political Affiliation is determined by the classification of the legislative 
composition in each state in 2014 per the National Conference of State 
Legislatures Partisan Composition of State Legislatures in 2014.  States were 
identified as Democrat, Republican or Split and were given values of 1, 2 or 3, 
respectively.  All states were reclassified based on the hospital divisions per the 
NIS dataset.  I took the legislative composition value (1, 2 or 3) by state and 
calculate the average legislative composition value by division.  To determine the 
Political Affiliation at the division level, I create a binary variable where any 
division average that is less than 2 is assigned 1 (Democrat) and averages over 2 
are assigned 0 (Republican). 
 Political Affiliation is correlated with the SDOH variables and is not 
correlated with the error term as evidenced by the Wald test of exogeneity. As a 
result, the second regression should be an IVProbit regression as follows: 
Y= β0 + β1Xi + β2W1i + β2W2i + β3W3i + ……. βnWni + u7 
Where: 
Y = Comorbidity (for each selected CM per regression there are separate 
regressions where the individual CM is the dependent variable) 
 
7 The TSLS estimator in the IVProbit regression is done in 2 stages.  In the first stage I regress X on instrumental 
Variable Z (Political Affiliation).  In the second stage I regress Y from the IVProvbit Regression TSLS on the predicted 
values and the included exogenous variables (W) using OLS including the intercept.  Please note, in the software used 
to do regressions, these steps are performed simultaneously. 
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Xi = SDOH – Endogenous Variable (using instrument Z such that Xi = 
π0 + πZ1i + πW1i + πW1i + πW1i + πW1i + πW1i + vi, where Z = Political 
Affiliation 
W1i – W6i = Race variables 
W7i = Gender variables 
W8i – W11i = Household Income variables 
W12i - W14i = Hospital Location variables 
W15i – W42i = All Other 28 CMs (not including the CM selected as the 
dependent variable. 
u = error term 
 The second regression requires each CM to be a dependent variable and 
be regressed against each SDOH in separate IVProbit regressions.   
Cost Savings Results 
 Next, I determine to what extent overall hospital COST could be reduced if 
the SDOH improved by one standard deviation for Violent Crime, Unemployment 
and SNAP.   Improving Violent Crime by one standard deviation means that the 
average number of incidents of violent crime per 100,000 people will decrease 
resulting in less violent crime.   Improving Unemployment by one standard 
deviation would mean that average unemployment rate would decrease.  For the 
comorbidities that cause COST to increase and that are caused by Violent Crime 
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or Unemployment (both represented by positive coefficients), the improvement 
by one standard deviation (also positive) will result in cost savings.  Improving 
SNAP by one standard deviation represent an increase in the average amount of 
SNAP funds per household which would ultimately decrease the level of food 
insecurity.  To reflect the effect on cost savings, I switch the sign of the standard 
deviation when calculating the COST savings because an improvement by one 
standard deviation has an inverse effect on the SNAP distribution.  For the 
comorbidities that both caused COST to increase and that are caused by 
circumstances around SNAP (i.e., food insecurity), the improvement by one 
standard deviation will determine the cost savings. 
I calculate the standard deviations for each SDOH variable.  To do this I 
use the average number of Violent Crime incidents, the average distribution per 
household for SNAP and the average Unemployment rate by Hospital Division8 
and calculate the standard deviation for each SDOH across all nine divisions for 
the full dataset.  Next, I take the coefficient for each SDOH variable from each 
CM IV Probit regression which represents the likelihood or probability that an 
individual with that SDOH (i.e., that lives in an area with Violent Crime) will also 
suffer from the specific CM (dependent variable) and multiply it by the one 
standard deviation for the SDOH variable.  This tells me the portion of the 
standard deviation improvement directly tied to the CM that is caused by the 
 
8 The dataset only went as granular as the Division which resulted in the Standard Deviation being artificially 
constrained as the SDOH amounts could only be one of 9 numbers.   
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SDOH.  Next, I use summary statistics to identify the total number of individuals 
with each CM by tabulating each CM from the full dataset and multiplying it by 
the portion of the standard deviation improvement directly tied to the CM.  This 
results in the total number of people with the CM that is caused by the SDOH, 
of which an improvement by one standard deviation would affect.  Lastly, I 
multiply the total number of people affected by the SDOH by the CM coefficient 
from the first regression which shows the CM’s effect on COST, to determine 
potential dollar savings.  This full calculation is outlined below in Table 1: 
Table 1 
 
V. Results from Empirical Research 
COST Regression  
I show there is an impact on hospital COST caused by the comorbidities 
while holding Length of Stay, Payer, Hospital Control, Hospital Bed Size and 
Service Line constant.  There are favorable and unfavorable effects on COST 
savings from the comorbidities.  The coefficient of the comorbidities that are 
positive indicates an unfavorable effect on COST and represented the 
incremental COST increase that results from a person having that specific 
comorbidity.  Figure 6 includes the coefficients of the Comorbidity with adverse 
effect on COST. 
 Comorbidity  
 Comorbidity  
Coeffient 
 Total  # of people 
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All comorbidity coefficients have p-values at or below 0.01.  There are also 
comorbidities that do not individually cause COST to increase while holding all 
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other variables constant.  Figure 7 includes these comorbidities and their 
coefficients. 
 Figure 7: 










These comorbidities are also statistically significant with p-value less than 0.01.   
It is important to note these additional comorbidities also plays a role in overall 
hospital COST impact since people with comorbidities must have at least two.  
This means that the COST of one comorbidity may be offset by the other or 
combined with another comorbidity.  
The results of this first regressions shows that comorbidities are a 
contributing factor in causing hospital COST to increase and negatively 
impacting hospital profitability.   
Instrumental Variable Probit Regression and Savings Calculation 
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The second regression is the instrumental variables probit (IVPROBIT).  I 
look to see if the SDOH (Violent Crime, SNAP, and Unemployment) causes the 
comorbidities that have the statistically significant adverse effect on COST.  I 
note that the three SDOH variables have a statistically significant impact on the 
following comorbidities with p-value less than 0.05: Alcohol, Congestive Heart 
Failure, Chronic Pulmonary disease, Coagulopathy, Depression, Diabetes 
without complications, Diabetes with complications, Hypertension, 
Hypothyroidism, Liver Disease, Lymphoma, Fluid and Electrolyte Disorders, 
Metastatic Cancer, Neurological Disorders, Obesity, Paralysis, Peripheral 
Vascular Disorder, Psychoses, Pulmonary Circulation, Renal Failure, Solid 
Tumor with Metastasis, Peptic Ulcer Disease and Weight Loss.   
To determine the estimated cost savings, calculated based on improving 
SDOH by one standard deviation, I split the cost savings into two categories.  The 
first category is direct COST savings which includes the calculated savings based 
on the specific comorbidities that has both a positive SDOH coefficient and a 
positive comorbidity coefficient.   Since both coefficients go in the same positive 
direction, the impact of the SDOH on the comorbidity flows through the 
comorbidity to COST, thus reflecting the COST savings attributed specifically to 
those comorbidities and SDOH variables.  The second category is Total Savings 
which includes the sum of all calculated cost savings for all statistically 
significant comorbidities.  As stated above, comorbidities are not mutually 
exclusive, therefore, it is important to include the net sum of all statistically 
significant comorbidities which would include some that do not have the same 
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positive directional effect on COST.  I present the calculated cost savings in 
dollars and as a percentage of total cost ($75,469,829,306.87) from the dataset.  
This enables me to highlight the full range of COST Savings that can be realized 
if the SDOH is improved by one standard deviation of 79.01795, 24.90658, and 
0.0082279 for Violent Crime, SNAP, and Unemployment, respectively.    
For Violent Crime (Appendix 2), the comorbidities that have positive 
comorbidity and SDOH coefficients are Coagulopathy, Diabetes without 
complication, Electrolyte Disorder and Weight Loss. Based on the total number 
of people with these comorbidities and improving violent crime by one standard 
deviation, I calculate the COST savings full range to be $119,514,400 through 
$160,967,652, where the $161M is the direct COST savings related to the four 
comorbidities that have positive comorbidity and SDOH coefficients and the 
$119.5M is the total COST savings.  Since the full range cost savings amounts 
are all positive, this indicates that if violent crime improves by one standard 
deviation, total hospital cost will decrease between 0.16% (total) and 0.21% 
(direct) and will result in a favorable impact on hospital profitability.  
For SNAP (Appendix 3), there are more comorbidities that have positive 
comorbidity and SDOH coefficients.  These comorbidities are Alcohol, Congestive 
Heart Failure, Chronic Pulmonary Disease, Drugs Abuse, Liver Disease, 
Lymphoma, Neurological Disorders, Obesity, Paralysis, Peripheral Vascular 
Disorder, Pulmonary Circulation, Renal Failure, and Peptic Ulcer Disease.  
Based on total number of people with these comorbidities and improving SNAP 
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by one standard deviation, I calculate the COST savings full range to be -
$203,904,405 through $368,063,384 where the -$204M is the direct COST 
savings related to the thirteen comorbidities that have positive comorbidity and 
SDOH coefficients and the $368M is the total COST savings.  The directly 
impacted comorbidities do not seem to result in any COST savings, however, the 
net effect of the range seems to reflect favorable COST savings.  Therefore I 
determine that since the full range cost savings amounts are all positive, this 
indicates that if SNAP distributions improve by one standard deviation, total 
hospital cost will decrease up to 0.5% (total) and will result in a favorable impact 
on hospital profitability,  but only if all comorbidities are taken into account.9  
For Unemployment (Appendix 4), the comorbidities that have positive 
comorbidity and SDOH coefficients are the same as the ones identified for Violent 
Crime (Coagulopathy, Diabetes without complication, Electrolyte Disorder and 
Weight Loss).   Based on the total number of people with these comorbidities and 
improving unemployment by one standard deviation, I calculate the potential 
COST savings full range to be $930,589,828 through $1,252,670,559, where the 
$1.3B is the direct COST savings related to the four comorbidities that have 
positive comorbidity and SDOH coefficients and the $930M is the total COST 
savings. As with violent crime, since the full range cost savings amounts are all 
positive, this indicates that if unemployment improves by one standard 
 
9 It is important to note that calculation for increasing by one standard deviation is adding to the average SNAP 
distribution per household so the calculation for standard deviation is a negative amount. 
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deviation, total hospital cost will decrease between 1.2% (total) and 1.7% (direct) 
and will result in a favorable impact on hospital profitability.        
Wald Test of Exogeneity 
To determine if the SDOH variables cause hospital COST to increase 
through the comorbidities, I run an instrumental variables regression (called 
IVPROBIT in Stata).  I suspect the SDOH variables are correlated with the error 
term and I use Political Affiliation as an instrument to isolate the piece of the 
SDOH variables that are uncorrelated with the error term.   The Wald Test of 
Exogeneity determines whether the instrumented variables are exogenous to the 
error term.  The goal of this test is to tell us if it is appropriate to use an 
instrumental variables regression over a regular probit regression.  The null 
hypothesis for the Wald Test of Exogeneity is that the instrumented variable (i.e., 
Violent Crime, SNAP or Unemployment) is not endogenous, therefore there would 
be no need to run an instrumental variables regression using Political Affiliation 
as the instrument.  If I reject the null hypothesis, that indicates that the 
instrumented variables are endogenous to the error term and the use of the 
Political Affiliation instrument was appropriate, therefore the IVProbit regression 
was appropriate. 
Based on the instrumental variables regressions for Violent Crime, SNAP 
and Unemployment that have statistically significant impact on the 
comorbidities that are identified as having direct COST savings, I am able to 
reject the null hypothesis of no endogeneity for all Violent Crime and 
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Unemployment regressions for the 4 effected comorbidities (Coagulopathy, 
Diabetes without Complication, Electrolyte Disorder and Weight Loss).  I also 
reject the null hypothesis of no endogeneity for SNAP for all of the effected 
comorbidities (Alcohol, Congestive Heart Failure, Chronic Pulmonary Disease, 
Drugs Abuse, Liver Disease, Lymphoma, Neurological Disorders, Obesity, 
Paralysis, Peripheral Vascular Disorder, Pulmonary Circulation, and Renal 
Failure) except for Peptic Ulcer Disease.  Since the chi2 value (p-value) for Peptic 
Ulcer Disease is greater than 0.05, this suggests that SNAP is not correlated with 
the error term and that a normal probit regression should be used.  I run a probit 
regression with Peptic Ulcer disease as the dependent variable and SNAP being 
the independent variable along with the same control variables that are used in 
the IVProbit regression but do not include Political Affiliation.  The original 
estimated COST savings under the instrumental variable’s regression was -
$122,652.  The total COST savings after removing Political Affiliation as an 
instrument and running a regular probit regression, was -$86,651 which is an 
increase of about 29%.  Therefore, I use the coefficient of SNAP for the probit 
regression of Peptic Ulcer disease to ensure my COST savings estimates are more 
accurate, however, it is important to note that the overall impact of the SNAP 
direct effect on COST savings is only 0.02%. 
Micro Analysis 
 As noted above, my results indicate that there is evidence that addressing 
SDOH by improving Violent Crime, Unemployment and SNAP by one standard 
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deviation will result in hospital cost savings and thereby, increase hospital 
profitability.  However, this analysis is at the macro level and may not specifically 
address the intricacies that exist across all diagnoses within a specific 
comorbidity.  Some specific diagnoses may be more (or less) sensitive to SDOH 
than others.  With that understanding I repeat my analysis done on the full 
population of this dataset, and run a micro analysis on a specific diagnosis 
related group (DRG) to determine if the correlation and causation of SDOH to 
hospital COST is still present.   
 I select an orthopedic procedure, DRG 470 – Major Joint Replacement or 
Reattachment of Lower Extremity Without Major Complication or Comorbidity.  
This DRG is most synonymous with knee replacements or hip fractures of 
patients that are not actively treating any complications or comorbidities at the 
time of surgery.  Some patients may have a history of comorbidities; however, 
the presence of those comorbidities would not influence the surgical procedure.  
If the patient is currently treating any chronic conditions or comorbidities with 
medication at the time of surgery, DRG 469 – Major Joint Replacement or 
Reattachment of Lower Extremity with Major Complication or Comorbidity, 
should be used.  I chose DRG 470 because the procedure is basic enough that 
anybody could receive it regardless of patient’s demographic or socioeconomic 
status.  It is a standard procedure that is most often performed very similarly 
regardless of the patient.  The goal of my micro analysis is to determine if there 
is a correlation and causal relationship between SDOH and comorbidities and if  
there are COST savings being driven by a one standard deviation improvement 
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in SDOH that have nothing to do with the procedure mix.  I calculate the COST 
savings in the micro analysis the exact same way as the macro analysis, using 
the total cost for the DRG 470 dataset which is $3,304,396,448.41.  
 Appendices 5, 6 and 7 details the results of the regression analysis for 
DRG 470.  The total number of observations in the DRG 470 subset data is 
209,368.  I apply the same methodology that was applied in the larger dataset 
noted in Appendices 2, 3 and 4 (including the same standard deviations).  Violent 
Crime (Appendix 5) appears to directly impact Congestive Heart Failure, Diabetes 
with no complications, Fluid and Electrolyte Disorders and Weight Loss.  If 
Violent Crime improves by one standard deviation, the full range of hospital 
COST savings are -$28,463,926 (-0.86% of total cost) to $1,058,154 (0.03% of 
total cost) where the $1.06M is the direct COST savings related to the 4 directly 
impacted comorbidities and the -$28.5M is the total COST savings.  The net 
effect of these COST savings is negative which indicates that decreasing Violent 
Crime will not result in an increase in hospital cost savings and will not have a 
favorable effect on hospital profitability.   
SNAP (Appendix 6) has a direct impact on eight comorbidities (Alcohol Abuse, 
Chronic Pulmonary Disease, Drug Abuse, Lymphoma, Obesity, Peripheral 
Vascular Disorders, Pulmonary Circulation and Renal Failure).  The effect of 
SNAP on hospital COST savings mirrors what I show from the larger dataset.  If 
SNAP is improved by one standard deviation, the full range of cost savings are -
$11,886,339 (-0.36% of total cost) to -$5,667,695 (-0.17% of total cost) where 
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the -$5.67M is the direct COST associated with the eight comorbidities and the 
-$11.88M is the total COST savings.  The net effect of these COST savings is 
negative which indicates that an improvement in SNAP will not result in an 
increase in hospital cost savings and will not have a favorable effect on hospital 
profitability.   
 Lastly, DRG 470 Unemployment (Appendix 7) directly impacts five 
comorbidities (Congestive Heart Failure, Diabetes with no complications, Fluid 
and Electrolytes Disorder, Other Neurological Disorders, and Weight Loss).  As 
with SNAP, Unemployment’s effect on hospital COST savings mirrors the results 
found in the larger main analysis above.  If Unemployment improves by one 
standard deviation, the full range of hospital COST savings are -$29,124,577 (-
0.88% of total cost) to $7,130,937 (0.22%) where the $7.1M is the direct COST 
savings related to the five directly impacted comorbidities and the -$29.1M is the 
total COST savings.  The net effect of these COST savings is negative which 
indicates that an improvement in Unemployment will not result in an increase 
in hospital cost savings and will not have a favorable effect on hospital 
profitability.   
 Although the results from the micro analysis does not support the overall 
results of the main analysis, it does not invalidate the overall conclusion that 
improving SDOH by one standard deviation will result in hospital cost savings.  
I used DRG 470 which is used when there are no major complications or 
comorbidities present at the time of surgery, therefore, I expected the aggregate 
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results from the micro analysis to differ from the main analysis because the 
existence of the comorbidities are not as sensitive to how this procedure is 
performed or how much it costs in comparison to DRG 469 which includes major 
complications and comorbidities at the time to surgery.  However, there still 
seems to be a correlation and causal relationship between directly impacted 
comorbidities and the SDOH resulting in COST savings of 0.03% for Violent 
Crime and 0.22% for Unemployment when improving SDOH by one standard. 
VI. Future Research 
This paper looks at the impact of Violent Crime, SNAP distributions and 
Unemployment on health outcomes and proved that an individual’s exposure to 
those social determinants not only causes less than favorable health outcomes, 
but also attributes to higher hospital costs and improving those social 
determinants will result in cost savings to the hospital.  However, these results 
in this paper should be cautiously considered given the limitations of available 
information from the NIS dataset as well as specific socioeconomic information 
that could have been used to provide a more detailed analysis of improvements 
in profitability and health outcomes.  There is so much information included in 
the NIS dataset, the variation of additional analyses on this topic are widespread.  
Therefore, I have narrowed it down to a couple of areas that I feel would provide 
a richer analysis of the impact of health outcomes and hospital profitability 
because of improving SDOH. 
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 This analysis has some constraints that prevent me from being able to 
analyze the information at a more granular level.  The NIS dataset does not break 
out inpatient discharge data at the state level.  The most detailed breakdown 
based on geographical information in the NIS dataset is at the Hospital Division 
level.  Having the hospital inpatient discharge information at the state level and 
further, at the zip code level, would provide a clearer picture of how impactful 
the area specific SDOH is on an individual’s health outcome.  Socioeconomic 
factors vary significantly from state to state and city to city, even when those 
cities and states have dominant political affiliations in common.  Additionally, 
the standard deviations at the zip code level and state level may vary from the 
Hospital Division level used in this paper.  Therefore, to really understand the 
impact of potential cost savings resulting from improving SDOH by one standard 
deviation, you would need to know the more granular standard deviation. 
There could also be some additional research specifically around Safety 
Net Hospitals.  Safety Net Hospitals are essential hospitals that provide 
healthcare to primarily uninsured, underinsured, and low-income individuals 
and those covered by Medicaid.  Given the population these hospitals serve, they 
are most at risk of skyrocketing costs as they see some of the sickest and poorest 
patients.  As previous research has shown, a person’s low-income status has an 
unfavorable effect on their health outcomes.  As a result, the Safety Net Hospitals 
would significantly benefit from cost savings derived from improving the SDOH 
of the population they serve.  All three SDOH indicators used in this paper would 
be relevant to use as a basis of analysis since low-income, uninsured individuals 
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are likely to live in areas with higher crimes rates, food insecurity and higher 
possibility of being unemployed.  Safety Net Hospitals’ primary payer is Medicaid, 
which pays close to $0.85-$0.87 on the dollar, and the Disproportionate Share 
Hospital Payments10 received from the government that is used to offset the cost 
of caring for low-income patients was recently cut and could mean a $44 billion 
reduction over the next 10 years, so improving the SDOH for the population they 
serve could significantly impact their profitability (Khullar et.al., 2018). 
My regression analysis, though informative, is really the first step as it 
relates to what could be done to explore opportunities for hospitals to obtain cost 
saving by improving SDOH.  The cost regression used the comorbidity’s 
coefficients as the base for calculating cost savings.  As mentioned earlier, 
comorbidities are present in an individual if they are deemed to have a 
comorbidity.  Therefore, it would be helpful to interact several comorbidities to 
see if it yields a larger comorbidity coefficient.  This would identify the 
combination of comorbidities that are driving the cost savings.  I tested this 
theory by looking at Diabetes with chronic complications (Diabetes) and 
Hypertension before and after interaction.  When I ran the first cost regression, 
the Diabetes coefficient was $103.94, and Hypertension’s coefficient was -
$46.37.  Violent Crime was shown to cause Diabetes in some respects and 
Diabetes attributed to higher cost evidenced by both regression’s coefficients 
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having the same positive directional impact, so improving Violent Crime would 
yield cost savings by the amount of impact Violent Crime had on Diabetes.  On 
the other hand, Hypertension’s coefficient was -$46.37, which means that 
Hypertension alone is not a contributing factor in higher cost, even though 
Violent Crime has an impact on Hypertension.  However, when I interact both 
Diabetes and Hypertension together, that coefficient was $70.25, which tells me 
that someone with both Diabetes and Hypertension as comorbidities attributes 
to higher healthcare cost, holding all other control variables constant. So, 
improving Violent Crime by one standard deviation would improve health 
outcomes of people with Diabetes and Hypertension, controlling for all other 
independent variables.  I would also recommend interacting some comorbidities 
against some of the other control variables in the IV analysis such as Race and 
Household Income Level.  As evidenced in prior research, certain minority 
populations (people of color) are more susceptible to some comorbidities based 
on their genetic makeup, or the likelihood that they may live in areas that are 
more impacted by socioeconomic factors.  Also, a patient’s income level could 
have a significant impact on their health outcomes because people are forced to 
have to choose between preventive care to keep from being chronically ill in the 
future and their livelihood now.   Improving SDOH in these cases could possibly 
have a significant impact on health outcomes and in turn result in cost savings. 
Another direction for future research is to rerun the analysis, taking into 
consideration, all SDOH assessed in this paper and additional SDOH not 
previously discussed in this paper including residential segregation, lack of 
P a g e  | 47 
 
 
education/literacy, and early childhood development.  There is a possibility that 
further analysis could identify additional cost savings when compared to all the 
variables originally analyzed.  There may also be more significant cost savings 
with other SDOH, that may be easier to address for a hospital or health system 
than the ones I analyzed in this paper.  I also think it would be interesting to see 
the impact of how all SDOH combined would impact health outcomes.  This 
would be done by adding instrumental variables in addition to Political Affiliation 
(IV regressions require the same number of instrumental variables as 
endogenous variables).  By combining multiple SDOH together in one regression, 
we could start to piece together what an actual economic policy would look like 
related to improving these SDOH and addressing skyrocketing healthcare cost. 
VII. Discussions on Processes and Policy Implications 
 Next, I address specific recommendations to improve these SDOH to yield 
the cost savings.   It is important to note that these process and policy 
recommendations are costly, and their cost needs to be considered together with 
the cost savings.  Unfortunately, we know that it will take more than the 
hospitals to invoke the type of improvements needed socioeconomically to see 
the improved health outcomes and increased profitability. However, given the 
information provided in this paper, hospitals can play a significant role in 
decreasing hospital cost associated with SDOH directly and indirectly. 
Direct Efforts 
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 Studies have shown that hospitals and health systems are starting to 
make financial investments in SDOH but the financial weight of those 
investments appear to be subpar considering how many hospitals are in the US 
and how impactful SDOH can be on their bottom line.  There are some good 
examples of health systems that are making a deliberate effort to combat SDOH 
such as Kaiser Permanente which has invested $200 million to combat 
homelessness in Oakland, CA through their Thriving Communities Fund 
(Johnson, 2018).  Unfortunately, this level of commitment is not quite 
widespread as it should be, and it may be because health systems have not been 
able to specifically tie return on investments (ROI) to the financial investments 
geared around improving SDOH.  Making deliberate financial investments shows 
that the health system is dedicated to the cause of addressing SDOH of their 
patient population.  According to Horwitz et al., (2020) health systems have 
publicly committed to investing in SDOH totaling close to $2.5 billion in the past 
two years.   However, their community benefit through subsidized and 
uncompensated care (i.e., writing off claims), totaled approximately $60 billion, 
with only about 5 percent or less as direct financial investments in activities that 
are not specifically health related.  From a financial perspective, it is easier to 
directly track the ROI from making deliberate financial investments as opposed 
to simply writing off unpaid claims or having it covered by charity care.   
 Another direct way to improve efforts around SDOH is for the health 
system to be more pro-active about screening patients when they are being 
admitted to the emergency room or for an inpatient stay by utilizing the new 
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SDOH diagnosis codes.  Indeed, data collection can be instrumental in 
identifying patterns upon admission by directly identifying the socioeconomic 
cause, enabling hospitals the opportunity to take swift action in mitigating 
unnecessary subsequent visits that could result in increased cost.  This would 
require providing additional training to front-line workers to be sensitive and 
aware of what to look for, what to ask, and how to handle these types of 
situations.  Health systems can also ramp up their community-health worker 
resources.  According to the American Public Health Association, Community 
Health Worker (CHW) is defined as, “a frontline public health worker who is a 
trusted member of and/or has an unusually close understanding of the 
community served. This trusting relationship enables the worker to serve as a 
liaison/link/intermediary between health/social services and the community to 
facilitate access to services and improve the quality and cultural competence of 
service delivery” (APHA, n.d.).  Hiring people whose primary job’s responsibility 
is to address SDOH of the patient is key to early high cost mitigation and 
improved health outcomes. CHWs can also work in collaboration with the 
provider (i.e., doctors) to help identify patients that may be more susceptible to 
SDOH.  Often time, providers only come in at the highest cost point which is 
when the patient has been admitted to the emergency room or for an inpatient 
stay.  Providers collaborating with the CHW can help mitigate overuse of 
inpatient services by identify issues that may be causing some of the acute 
reasons for admission. 
Indirect Efforts 
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 Cross-functional collaboration is a must for health systems to really reap 
the cost savings derived from improving SDOH.  In addition to all the direct 
efforts noted above, health systems will need to look beyond their walls for 
assistance to combat these SDOH that are driving up cost and causing less than 
favorable health outcomes.  One way to do this is to establish and improve 
relationships with community organizations with a specific focus on SDOH.  This 
can be done by financially supporting some of those organizations’ initiatives or 
collaborating with the organizations on those initiatives.  An example would be 
ProMedica, an Ohio based health system that co-founded the Root Cause 
Coalition, a non-for-profit collaborative of health systems, health insurance 
companies, and community organizations geared around addressing causes of 
health inequity (Johnson, 2018, p.8).  These types of investments allow dual 
benefits as it helps solidify the health system’s position on moral and social 
responsibility to the community they serve, and it will ultimately improve their 
profitability as discussed in this paper. 
 Health systems should also ensure that their interest around SDOH are 
legislatively represented.  In addition to securing lobbyist  to address restrictions 
around healthcare reimbursement rates from government and commercial 
insurance payers, they should also ensure their interest is represented in other 
areas that may not directly affect healthcare economic policy but directly affects 
socioeconomic factors.  This may include supporting candidates with platforms 
geared around improving the SDOH that are most impactful to the communities 
served by the health system.  This could be a controversial suggestion especially 
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in today’s climate; however, this paper empirically proves that political affiliation 
is a driver for the elasticity of hospital cost savings because of improved SDOH.  
Also, linking socioeconomic policies to health outcomes is not a new 
phenomenon.  Adler and Newman (2002) discussed several policies that are 
designed to directly impact an individual’s socioeconomic status such as labor-
market policies, redistributive policies and policies affecting environmental 
exposures to name a few.   
Labor market policies are geared around improving overall labor market 
outcomes while supporting and protecting the workers.  Some policies related to 
labor market would be the fight for livable wages (i.e., increasing minimum 
wage), unemployment insurance, and transitions from manual low-skilled labor 
to STEM.  Redistributive polices are policies where government funds are used 
to invest in reducing economic inequalities.  Sometimes these types of polices 
can be looked at as being extreme liberal/socialist leaning, but this is not a new 
or extreme idea.  As a matter of fact, programs like Head Start11, food stamps 
and even Medicare can be viewed as redistributive policies.  These policies allow 
low-income individuals to have an opportunity to be at the same level playing 
field as higher income individuals, thereby eliminating detrimental disparities 
that can negatively affect health outcomes.  Policies affecting environmental 
exposures primarily consist of policies that aim to limit or eliminate pollution, 
promote clean air, and clean energy, and climate change.  Often time, people of 
 
11 According to Benefits.gov, “Head Start is a Federal program that promotes the school readiness of children from 
birth to age five from low-income families by enhancing their cognitive, social, and emotional development.  More 
details on program can be found at https://www.benefits.gov/benefit/616  
P a g e  | 52 
 
 
color and low-income individuals live in areas that are highly impacted by 
hazardous environmental pollutants that ultimately have a negative effect on 
health outcomes.  These policies amongst others, are not specifically healthcare 
policies but can impact an individual’s health care.   
VIII. Conclusion 
 This paper provides empirical evidence that SDOH causes unfavorable 
health outcomes which causes hospital inpatient cost to increase attributing to 
the erosion of hospital profitability. If the circumstances around those SDOH 
were improved, hospital profitability would improve.  I assume that since the 
SDOH causes unfavorable effects on health outcomes, the improvements of those 
SDOH would improve health outcomes.  Overall, I conclude that improving 
Violent Crime, SNAP and Unemployment by one standard deviation will result in 
hospital cost savings as follows: total hospital cost would decrease between 
0.16% and 0.21% for Violent Crime, up to 0.5% for SNAP and between 1.2% and 
1.7% for unemployment resulting in a favorable impact on hospital profitability.  
The dataset used in this analysis prevented me from being able to go more 
granular, so more detailed analysis at the state, city and zip code level would 
give a more precise estimation of possible cost savings related to SDOH 
improvements.  This paper introduces IV analysis and found endogeneity with 
the SDOH variables and uses political affiliation as the instrument to isolate the 
exogenous portion of the SDOH.   
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 There are few studies, if any, that directly ties the improvement of SDOH 
to hospital profitability.  However, based on the findings in this paper, causality 
between SDOH and hospital cost has been established.  The future research in 
this area would be vital for all hospitals and health systems and has the potential 
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